1-2 of 2
Suman Redhu
Close
Sort by
Journal Articles

Efficacy and Safety Based on Duration of Treatment of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma in the Phase 3 Panorama 1 Study

Jesus San Miguel, MD PhD, Vania TM Hungria, Sung-Soo Yoon, MD PhD, Meral Beksac, MD, Meletios A. Dimopoulos, Ashraf Elghandour, MD, Wieslaw Wiktor Jedrzejczak, MD, Andreas Guenther, MD, Thanyaphong Na Nakorn, MD PhD, Noppadol Siritanaratkul, MD, Robert L Schlossman, MD, Jian Hou, MD PhD, Philippe Moreau, MD, Sagar Lonial, MD, Jae-Hoon Lee, Hermann Einsele, MD, Hans Salwender, MD, Monika Sopala, Suman Redhu, Sofia Paul, PhD, Claudia Corrado, Florence Binlich, Paul G. Richardson
Journal: Blood
Blood (2014) 124 (21): 4742.
https://doi.org/10.1182/blood.V124.21.4742.4742
Published: 2014
Journal Articles

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Vania T M Hungria, MDPhD, Sung-Soo Yoon, MD PhD, Meral Beksac, MD, Meletios A. Dimopoulos, MD, Ashraf Elghandour, MD, Wieslaw Wiktor Jedrzejczak, MD, Andreas Guenther, MD, Thanyaphong Na Nakorn, MD PhD, Noppadol Siritanaratkul, MD, Robert L. Schlossman, MD, Jian Hou, MD PhD, Philippe Moreau, Sagar Lonial, MD, Jae Hoon Lee, MD PhD, Hermann Einsele, Hans Salwender, MD, Monika Sopala, Ashok Panneerselvam, Suman Redhu, Claudia Corrado, Florence Binlich, Jesus F. San Miguel
Journal: Blood
Blood (2014) 124 (21): 2120.
https://doi.org/10.1182/blood.V124.21.2120.2120
Published: 2014